Terms: = Liver cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1676 results:
1. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
2. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced liver MRI.
Yoon JH; Kim YK; Kim JW; Chang W; Choi JI; Park BJ; Choi JY; Kim SS; Park HS; Lee ES; Yu JS; Park SJ; You MW; Lee CH; Lee JM
Radiology; 2024 Apr; 311(1):e233114. PubMed ID: 38563667
[TBL] [Abstract] [Full Text] [Related]
4. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Strassmann V; Wexner SD
Int J Colorectal Dis; 2024 Mar; 39(1):43. PubMed ID: 38538931
[TBL] [Abstract] [Full Text] [Related]
5. A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability.
Moreau M; Alouani E; Flecchia C; Falcoz A; Gallois C; Auclin E; André T; Cohen R; Hollebecque A; Turpin A; Pernot S; Masson T; Di Fiore F; Dutherge M; Mazard T; Hautefeuille V; Van Laethem JL; De la Fouchardière C; Perkins G; Ben-Abdelghani M; Sclafani F; Aparicio T; Kim S; Vernerey D; Taieb J; Guimbaud R; Tougeron D
Eur J Cancer; 2024 May; 202():114033. PubMed ID: 38537314
[TBL] [Abstract] [Full Text] [Related]
6. Aspirin for Metabolic Dysfunction-Associated Steatotic liver Disease Without Cirrhosis: A Randomized Clinical Trial.
Simon TG; Wilechansky RM; Stoyanova S; Grossman A; Dichtel LE; Lauer GM; Miller KK; Hoshida Y; Corey KE; Loomba R; Chung RT; Chan AT
JAMA; 2024 Mar; 331(11):920-929. PubMed ID: 38502074
[TBL] [Abstract] [Full Text] [Related]
7. Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
Eigler C; McDougall L; Bauman A; Bernhardt P; Hentschel M; Blackham KA; Nicolas G; Fani M; Wild D; Cordier D
J Nucl Med; 2024 Apr; 65(4):573-579. PubMed ID: 38423782
[TBL] [Abstract] [Full Text] [Related]
8. A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Enzler T; Nguyen A; Misleh J; Cline VJ; Johns M; Shumway N; Paulson S; Siegel R; Larson T; Messersmith W; Richards D; Chaves J; Pierce E; Zalupski M; Sahai V; Orr D; Ruste SA; Haun A; Kawabe T
Eur J Cancer; 2024 Apr; 201():113950. PubMed ID: 38422585
[TBL] [Abstract] [Full Text] [Related]
9. Case 322: Pyothorax-associated Lymphoma.
Hu JY; Lee KH; Yun G
Radiology; 2024 Feb; 310(2):e223090. PubMed ID: 38411510
[TBL] [Abstract] [Full Text] [Related]
10. A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran.
Tirgar Fakheri S; Shokri-Afra H; Graham DY; Bari Z; Fakheri H
Helicobacter; 2024; 29(1):e13061. PubMed ID: 38411303
[TBL] [Abstract] [Full Text] [Related]
11. The Effect of Tegoprazan on the treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study.
Kim BW; Park JJ; Moon HS; Lee WS; Shim KN; Baik GH; Lim YJ; Lee HL; Youn YH; Park JC; Sung IK; Chung H; Moon JS; Kim GH; Hong SJ; Choi HS
Gut Liver; 2024 Mar; 18(2):257-264. PubMed ID: 38384180
[TBL] [Abstract] [Full Text] [Related]
12. Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies.
El-Wakil MH; El-Dershaby HA; Ghazallah RA; El-Yazbi AF; Abd El-Razik HA; Soliman FSG
Bioorg Chem; 2024 Apr; 145():107226. PubMed ID: 38377818
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.
Qiu X; Lu C; Sha H; Zhu Y; Kong W; Tong F; Wang Q; Meng F; Liu B; Du J
Front Immunol; 2024; 15():1210859. PubMed ID: 38361920
[TBL] [Abstract] [Full Text] [Related]
14. Hepatocellular Carcinoma Epigenetic Patterns Correspond to Differences in Ethnoracial Status and treatment Response in a Single-Center Retrospective Study.
Vijayakumar V; Gaba RC; Huang YH; Davis I; Roman R; Guzman G; Lokken RP; Schachtschneider KM
J Vasc Interv Radiol; 2024 May; 35(5):731-743.e36. PubMed ID: 38320622
[TBL] [Abstract] [Full Text] [Related]
15. CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
Auer TA; Müller L; Schulze D; Anhamm M; Bettinger D; Steinle V; Haubold J; Zopfs D; Pinto Dos Santos D; Eisenblätter M; Gebauer B; Kloeckner R; Collettini F
Radiology; 2024 Feb; 310(2):e232044. PubMed ID: 38319166
[TBL] [Abstract] [Full Text] [Related]
16. Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma.
Hu EY; Bhagavatula SK; Shi A; Merriam P; Levesque VM; Shyn PB
Abdom Radiol (NY); 2024 Apr; 49(4):1241-1247. PubMed ID: 38240859
[TBL] [Abstract] [Full Text] [Related]
17. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
[TBL] [Abstract] [Full Text] [Related]
18. The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate cancer (mCRPC) Treated with Abiraterone or Enzalutamide.
Halabi S; Guo S; Park JJ; Nanus DM; George DJ; Antonarakis ES; Danila DC; Szmulewitz RZ; McDonnell DP; Norris JD; Lu C; Luo J; Armstrong AJ
Clin Cancer Res; 2024 Mar; 30(6):1152-1159. PubMed ID: 38236581
[TBL] [Abstract] [Full Text] [Related]
19. Radiomics Features Extracted From Pre- and Postprocedural Imaging in Early Prediction of treatment Response in Patients Undergoing Transarterial Radioembolization of Hepatic Lesions: A Systematic Review, Meta-Analysis, and Quality Appraisal Study.
Mirza-Aghazadeh-Attari M; Srinivas T; Kamireddy A; Kim A; Weiss CR
J Am Coll Radiol; 2024 May; 21(5):740-751. PubMed ID: 38220040
[TBL] [Abstract] [Full Text] [Related]
20. VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.
Coffman-D'Annibale K; Myojin Y; Monge C; Xie C; Hrones DM; Wood BJ; Levy EB; Kleiner D; Figg WD; Steinberg SM; Redd B; Greten TF
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38184304
[TBL] [Abstract] [Full Text] [Related]
[Next]
